Ascentage’s drug shows potential to treat Covid-19 in preclinical study
Olverembatinib showed increased Omicron-NTD-mediated cytokine release suppression compared with ponatinib and baricitinib.

Olverembatinib showed increased Omicron-NTD-mediated cytokine release suppression compared with ponatinib and baricitinib.
A growing base of evidence suggests people are significantly more likely to develop diabetes in the months following a Covid-19…
ByThe data was inadequate to conclude that the drug was effective in preventing disease progression, FDA noted.
Moderna’s positioning as US contractor for Covid-19 vaccines in a patent lawsuit marks a new development in the infringement disputes.
ByThe grant will support two trials of ebselen in 120 adult subjects with moderate or severe Covid-19.
The approval is based on findings from two Phase III clinical trials, ACTT-2 and COV-BARRIER.
The health concern over COVID-19 in April 2022 decreased from March, shows the COVID-19 concern index, which is measured by…
The tools established to combat Covid-19 can be proactively leveraged before the hepatitis outbreak becomes any more serious.
ByThank you for subscribing to Pharmaceutical Technology